Lilly's Online, Interactive Health Education Program Receives Two Web Awards

LillyLilly USA recently was recognized by the eHealthcare Leadership Awards and the Web Marketing Association for its Health Education Answers program, an interactive health and wellness tool.

Health Education Answers is a free, Web-based program designed to help managed care and public payer organizations further drive the quality of patient care through educational outreach. This tool, which also is available in DVD-ROM format, educates patients on several health areas, including proper diet and exercise, healthy habits to teach children, and simple steps to help individuals and families prevent or manage illness.

At the 13th Annual Healthcare Internet Conference, Health Education Answers received an eHealthcare Leadership Award of Distinction for Best Care/Disease Management Site for the online tool's ability to help consumers manage a chronic condition, encourage two-way communication between patient and health care practitioners, and provide opportunities to monitor clinical care. More than 1,100 entries were received from a wide range of health care organizations, online health companies, pharmaceutical/medical equipment firms, suppliers and business improvement initiatives.

In addition, Health Education Answers received the 2009 Health Care Standard of Excellence Award from the Web Marketing Association. This award recognizes the people and organizations responsible for developing some of the most effective Web sites on the Internet today.

"Lilly is honored to be recognized by both the eHealthcare Leadership Awards and the Web Marketing Association for Health Education Answers," said Alex M. Azar II, vice president, Lilly USA. "These external awards give credibility to the fact that Health Education Answers is an easy-to-use and effective health and wellness program. We're proud to provide managed care and public payer organizations with this educational option that gives their plan members the tools they need to improve and maintain their health."

About Health Education Answers
Available in Spanish and English and with portions in Mandarin, Health Education Answers is based on research-supported patient education material that adheres to national clinical guidelines. Patients accessing the program can progress through several health and disease management modules, including ADHD, Bipolar Disorder, Depression, Diabetes, Diabetes Complications, Heart Health, Manage Your Weight, Medication Safety, Men's Health, Schizophrenia, Smoking and Addictions, Wellness and Women's Health.

The program also includes an optional health risk assessment, which helps patients identify and understand their individual health needs and at-risk behaviors. Based on the results, Health Education Answers directs patients to the most applicable education modules that provide tips for improvement.

The tool can be customized to meet each organization's individual needs, including incorporating the organization's logo, approved color palette, specific content selections and a personalized welcome message.

Other Recognitions
Health Education Answers received the Health on the Net Foundation's Code of Conduct (HONcode) certification. The HONcode is a voluntary certification system that aims to raise the quality of health care information available on the Internet. Health information Web sites that receive HONcode certification have been evaluated by the organization for providing reliable and credible health information, as well as data confidentiality, proper attribution of sources and transparency of financial sponsorship.

In 2008, Health Education Answers received Health Information Product Certification from the National Committee for Quality Assurance (NCQA) in the area of Health Risk Appraisals and Interactive Consumer Health Tools. NCQA is a private, nonprofit organization dedicated to providing health care quality information in order to help consumers, employers and others make more informed health care choices. Lilly is the first and only pharmaceutical company in the nation to receive this NCQA program status.

About Eli Lilly and Company
Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. For additional information on Health Education Answers or Lilly's other patient care and disease management programs, visit www.lillyforbetterhealth.com.

Most Popular Now

Pfizer announces positive top-line results from Ph…

Pfizer Inc. (NYSE: PFE) today announced positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene elaparvovec, an investigational ...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

Enzyme that protects against viruses could fuel ca…

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a ...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...